Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Spadafora

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical EvidenceAmro Abu Suleiman, Vincenzo Quagliariello, Luigi Spadafora, et al.
Journal of Cardiovascular Pharmacology|April 18, 2023
Ginsenoside Re: Are we Close to a Safer Antiplatelet Therapy?Matteo Betti, Marco Bernardi, Giampaolo Niccoli, et al.
Archives of Medical Science : AMS|April 10, 2023
Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients?Marco Bernardi, Luigi Spadafora, Mattia Galli, et al.
Journal of Cardiovascular Pharmacology|January 23, 2025
Patient-Reported Outcome Measures in Cardiovascular Research and Care: PRO(M)s and CONSGiuseppe Biondi-Zoccai, Giacomo Frati, Mariangela Peruzzi, et al.
Pharmaceutics|January 21, 2023
Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of NanotechnologiesAdelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|September 30, 2024
Obesity and cardiovascular disease: Risk assessment, physical activity, and management of complicationsFrancesco Perone, Luigi Spadafora, Alessandra Pratesi, et al.
Minerva Cardiology and Angiology|June 20, 2023
Impact of low-dose Brain-Derived Neurotrophic Factor (BDNF) on atrial fibrillation recurrenceMassimo Fioranelli, Luigi Spadafora, Marco Bernardi, et al.
Giornale Italiano Di Cardiologia (2006)|February 25, 2026
[Artificial intelligence in cardiology: the new HAL 9000?]Marco Bernardi, Luigi Spadafora, Laura Adelaide Dalla Vecchia, et al.
Current Cardiology Reports|February 11, 2025
From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent EraLuigi Spadafora, Rossella Quarta, Giovanni Martino, et al.
Current Problems in Cardiology|March 1, 2024
Mechanical Cardiopulmonary Resuscitation Devices: Evidence Synthesis with an Umbrella ReviewAngela Buonpane, Carlo De Innocentiis, Marco Bernardi, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical EvidenceAmro Abu Suleiman, Vincenzo Quagliariello, Luigi Spadafora, et al.
Journal of Cardiovascular Pharmacology|April 18, 2023
Ginsenoside Re: Are we Close to a Safer Antiplatelet Therapy?Matteo Betti, Marco Bernardi, Giampaolo Niccoli, et al.
Archives of Medical Science : AMS|April 10, 2023
Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients?Marco Bernardi, Luigi Spadafora, Mattia Galli, et al.
Journal of Cardiovascular Pharmacology|January 23, 2025
Patient-Reported Outcome Measures in Cardiovascular Research and Care: PRO(M)s and CONSGiuseppe Biondi-Zoccai, Giacomo Frati, Mariangela Peruzzi, et al.
Pharmaceutics|January 21, 2023
Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of NanotechnologiesAdelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|September 30, 2024
Obesity and cardiovascular disease: Risk assessment, physical activity, and management of complicationsFrancesco Perone, Luigi Spadafora, Alessandra Pratesi, et al.
Minerva Cardiology and Angiology|June 20, 2023
Impact of low-dose Brain-Derived Neurotrophic Factor (BDNF) on atrial fibrillation recurrenceMassimo Fioranelli, Luigi Spadafora, Marco Bernardi, et al.
Giornale Italiano Di Cardiologia (2006)|February 25, 2026
[Artificial intelligence in cardiology: the new HAL 9000?]Marco Bernardi, Luigi Spadafora, Laura Adelaide Dalla Vecchia, et al.
Current Cardiology Reports|February 11, 2025
From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent EraLuigi Spadafora, Rossella Quarta, Giovanni Martino, et al.
Current Problems in Cardiology|March 1, 2024
Mechanical Cardiopulmonary Resuscitation Devices: Evidence Synthesis with an Umbrella ReviewAngela Buonpane, Carlo De Innocentiis, Marco Bernardi, et al.
Pageof 9